Étude de marché pharmaceutique

La santé et le bien-être font partie intégrante de la vie.  

These sectors relate to the development, manufacture, and marketing of medicines.  The global revenue of the pharmaceutical industry is more than $1 trillion. Almost half of this figure comes from two countries: the US and Canada. It is by far the most profitable industry of all. The primary and generic pharmaceutical companies lead the way in the industry.

Certaines des percées de l’industrie proviennent de sociétés pharmaceutiques spécialisées. Certaines de ces entreprises comptent moins d’employés qu’un seul département d’une des plus grandes entreprises. Ces petits établissements ont un immense impact sur les patients. Ils se concentrent sur les domaines thérapeutiques et les marchés de niche. Ces entreprises montrent comment une approche ciblée peut donner des résultats. Certaines entreprises se concentrent entièrement sur une seule maladie. D'autres traitent des maladies qui ne touchent qu'une minorité de la population.

The US pharmaceutical market dominates the rest of the world. The US is an innovator and a booster in the field of medical research and development. Their R&D benefits the international pharmaceutical industry. Still, one of the top conditions affecting US patients is diabetes. Oncology and autoimmune diseases are also the focus of much research in the US. Pfizer, Johnson & Johnson, and Merck & Co. are the largest companies on the US market.

Tendances du marché pharmaceutique

Public Relations (PR) and Advertising are powerful for Pharma companies.  One of the most prominent is the consumer as customer. Biotech stories are starting to proliferate. One such story involves the use of gene therapy to regrow the skin of a little boy.  As drugs get personalized, stories such as these are capturing imaginations. They are also piquing people’s interest in the sector.  

Patient stories can be powerful.  Negative publicity can also be influential.  One pharma company made headline news for charging $1,000 per day to treat hepatitis, creating a slew of negative publicity.  It’s a brave – and complex new world for biotech and pharmaceutical companies.

There are several challenges in the pharmaceutical industry. These include policy reforms. For example, healthcare officials are likely to overhaul the Affordable Care Act soon. Another problem is the impact of new technologies. Industry players are still doubtful about the effects of these technologies. It is unclear how they will affect drug development and commercialization.  Gene therapy and Gene editing are also gaining more headlines on opportunities and challenges in those sectors.

Opportunités pharmaceutiques mondiales

Pharmaceutical sales are the largest in the US and Europe. Developed markets for pharmaceuticals comprise the United States and Western L'Europe. Canada, Japan, and Australia are also part of this market.  The United States sells approximately 33%, Western Europe, 22%, and China, 10%. Japan accounts for 9% Latin America, 7%, and Russia, 4%. South Korea, India, Indonesia, and Australia are below 3%. 

Marketing d'influence pharmaceutique

One of the digital trends in pharma is influencer marketing. An influencer is one who is active in one or more of the social channels, with a large follower base. Pharma companies have been using influencers. These influencers have been reporting on their use of certain drugs and devices. They are also influencing people’s behavior in the area of disease prevention. Influencers can also encourage adherence to treatment protocols.  Support groups can be highly influential in treatment and patient behavior.

Populations vieillissantes

L’un des moteurs de croissance de l’industrie pharmaceutique est le vieillissement de la population aux États-Unis et dans la plupart des économies avancées. Un autre facteur de croissance est l’augmentation du nombre de personnes ayant un mode de vie malsain. Ces mauvais choix incluent le manque d’exercice quotidien et des habitudes alimentaires malsaines.

The USA and Europe are leaders in pharmaceutical development and use. Other areas like India and China have seen growth in recent years in the life science markets. The cause of this growth is an increasing demand for devices and products. It is also because of substantial capital opportunities. 

Solutions d'études de marché pharmaceutique

SIS International Research has over 40+ years of experience in Marché Research and Strategy Consulting in the Pharmaceutical industry.  We conduct research with patients, caretakers, physicians, payors, influencers, regulators, and other stakeholders.

Nous fournissons:

• Groupes de discussion
• Communautés Insight en ligne
• Entretiens approfondis
• Enquêtes en ligne
• Études de marché multi-pays et internationales
• Market Entry, Sizing, and Opportunity
• Analyse stratégique et concurrentielle